Ron Belldegrun

Perrigo has agreed to sell its US infant formula business to MeridianMade for up to $175 million, although only $40 million is payable at closing. The planned divestiture could improve margins and reduce future manufacturing investment, but a substantial impairment charge and weak growth in its remaining consumer health business complicate the turnaround.